Acumen Pharmaceuticals Is Maintained at Buy by Citigroup
Ratings actions GMT) Acumen Pharmaceuticals Price Target Raised to $5.00/Share From $4.00 by CitigroupRatings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.